Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Non-Current Debt (2019 - 2024)

Historic Non-Current Debt for Cresco Labs (CRLBF) over the last 6 years, with Q3 2024 value amounting to $499.3 million.

  • Cresco Labs' Non-Current Debt rose 180.04% to $499.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $499.3 million, marking a year-over-year increase of 180.04%. This contributed to the annual value of $497.7 million for FY2023, which is 436.62% up from last year.
  • As of Q3 2024, Cresco Labs' Non-Current Debt stood at $499.3 million, which was up 180.04% from $498.7 million recorded in Q2 2024.
  • Cresco Labs' Non-Current Debt's 5-year high stood at $499.3 million during Q3 2024, with a 5-year trough of $255.4 million in Q4 2020.
  • Moreover, its 5-year median value for Non-Current Debt was $483.7 million (2022), whereas its average is $462.4 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first surged by 4634345.45% in 2020, then soared by 180.04% in 2024.
  • Cresco Labs' Non-Current Debt (Quarter) stood at $255.4 million in 2020, then soared by 82.07% to $465.1 million in 2021, then grew by 2.54% to $476.9 million in 2022, then grew by 4.37% to $497.7 million in 2023, then grew by 0.33% to $499.3 million in 2024.
  • Its Non-Current Debt stands at $499.3 million for Q3 2024, versus $498.7 million for Q2 2024 and $498.0 million for Q1 2024.